PL377319A1 - Pochodne benzofuranowe i ich zastosowanie jako środków antydepresyjnych i anksjolitycznych - Google Patents

Pochodne benzofuranowe i ich zastosowanie jako środków antydepresyjnych i anksjolitycznych

Info

Publication number: PL377319A1
Authority: PL; Poland
Prior art keywords: derivatives; cor; halo; alkyl; disclosure
Prior art date: 2003-02-11

Application number

PL377319A

Other languages

English (en)

Inventor

Günter Hölzemann

Henning Böttcher

Kai Schiemann

Timo Heinrich

Joachim Leibrock

Amsterdam Christoph Van

Gerd Bartoszyk

Christoph Seyfried

Original Assignee

Merck Patent Gmbh

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2003-02-11

Filing date

2004-01-10

Publication date

2006-01-23

2004-01-10 Application filed by Merck Patent Gmbh filed Critical Merck Patent Gmbh

2006-01-23 Publication of PL377319A1 publication Critical patent/PL377319A1/pl

Links

239000000935 antidepressant agent Substances 0.000 title abstract 2
229940005513 antidepressants Drugs 0.000 title abstract 2
IANQTJSKSUMEQM-UHFFFAOYSA-N 1-benzofuran Chemical class C1=CC=C2OC=CC2=C1 IANQTJSKSUMEQM-UHFFFAOYSA-N 0.000 title 1
239000002249 anxiolytic agent Substances 0.000 title 1
230000000949 anxiolytic effect Effects 0.000 title 1
229940005530 anxiolytics Drugs 0.000 title 1
125000000217 alkyl group Chemical group 0.000 abstract 2
125000001475 halogen functional group Chemical group 0.000 abstract 2
QZAYGJVTTNCVMB-UHFFFAOYSA-N serotonin Chemical compound C1=C(O)C=C2C(CCN)=CNC2=C1 QZAYGJVTTNCVMB-UHFFFAOYSA-N 0.000 abstract 2
102100022738 5-hydroxytryptamine receptor 1A Human genes 0.000 abstract 1
101710138638 5-hydroxytryptamine receptor 1A Proteins 0.000 abstract 1
102000040125 5-hydroxytryptamine receptor family Human genes 0.000 abstract 1
108091032151 5-hydroxytryptamine receptor family Proteins 0.000 abstract 1
208000001953 Hypotension Diseases 0.000 abstract 1
239000000556 agonist Substances 0.000 abstract 1
125000003545 alkoxy group Chemical group 0.000 abstract 1
230000001539 anorectic effect Effects 0.000 abstract 1
125000002178 anthracenyl group Chemical group C1(=CC=CC2=CC3=CC=CC=C3C=C12)* 0.000 abstract 1
230000001430 anti-depressive effect Effects 0.000 abstract 1
230000003110 anti-inflammatory effect Effects 0.000 abstract 1
230000002460 anti-migrenic effect Effects 0.000 abstract 1
230000001966 cerebroprotective effect Effects 0.000 abstract 1
150000001907 coumarones Chemical class 0.000 abstract 1
206010061428 decreased appetite Diseases 0.000 abstract 1
239000003814 drug Substances 0.000 abstract 1
230000000694 effects Effects 0.000 abstract 1
125000004029 hydroxymethyl group Chemical group [H]OC([H])([H])* 0.000 abstract 1
230000000147 hypnotic effect Effects 0.000 abstract 1
208000021822 hypotensive Diseases 0.000 abstract 1
230000001077 hypotensive effect Effects 0.000 abstract 1
239000003112 inhibitor Substances 0.000 abstract 1
230000010534 mechanism of action Effects 0.000 abstract 1
239000000203 mixture Substances 0.000 abstract 1
125000001624 naphthyl group Chemical group 0.000 abstract 1
239000003176 neuroleptic agent Substances 0.000 abstract 1
230000000701 neuroleptic effect Effects 0.000 abstract 1
230000000324 neuroprotective effect Effects 0.000 abstract 1
230000001777 nootropic effect Effects 0.000 abstract 1
125000004043 oxo group Chemical group O=* 0.000 abstract 1
238000004806 packaging method and process Methods 0.000 abstract 1
125000001792 phenanthrenyl group Chemical group C1(=CC=CC=2C3=CC=CC=C3C=CC12)* 0.000 abstract 1
125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 abstract 1
239000012453 solvate Substances 0.000 abstract 1
229940125725 tranquilizer Drugs 0.000 abstract 1
239000003204 tranquilizing agent Substances 0.000 abstract 1
230000002936 tranquilizing effect Effects 0.000 abstract 1

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/14—Prodigestives, e.g. acids, enzymes, appetite stimulants, antidyspeptics, tonics, antiflatulents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/08—Drugs for genital or sexual disorders; Contraceptives for gonadal disorders or for enhancing fertility, e.g. inducers of ovulation or of spermatogenesis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/10—Drugs for genital or sexual disorders; Contraceptives for impotence
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/06—Antimigraine agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/20—Hypnotics; Sedatives
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/26—Psychostimulants, e.g. nicotine, cocaine
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Chemical Kinetics & Catalysis (AREA)
Veterinary Medicine (AREA)
General Chemical & Material Sciences (AREA)
Medicinal Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Public Health (AREA)
Pharmacology & Pharmacy (AREA)
Life Sciences & Earth Sciences (AREA)
Animal Behavior & Ethology (AREA)
General Health & Medical Sciences (AREA)
Biomedical Technology (AREA)
Neurology (AREA)
Neurosurgery (AREA)
Psychiatry (AREA)
Reproductive Health (AREA)
Heart & Thoracic Surgery (AREA)
Gynecology & Obstetrics (AREA)
Endocrinology (AREA)
Cardiology (AREA)
Pain & Pain Management (AREA)
Psychology (AREA)
Vascular Medicine (AREA)
Diabetes (AREA)
Hematology (AREA)
Obesity (AREA)
Anesthesiology (AREA)
Pregnancy & Childbirth (AREA)
Hospice & Palliative Care (AREA)
Urology & Nephrology (AREA)
Nutrition Science (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Furan Compounds (AREA)
Plural Heterocyclic Compounds (AREA)
External Artificial Organs (AREA)

PL377319A 2003-02-11 2004-01-10 Pochodne benzofuranowe i ich zastosowanie jako środków antydepresyjnych i anksjolitycznych PL377319A1 (pl)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
DE10305739A DE10305739A1 (de)	2003-02-11	2003-02-11	Benzofuranderivate

Publications (1)

Publication Number	Publication Date
PL377319A1 true PL377319A1 (pl)	2006-01-23

Family

ID=32730991

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
PL377319A PL377319A1 (pl)	2003-02-11	2004-01-10	Pochodne benzofuranowe i ich zastosowanie jako środków antydepresyjnych i anksjolitycznych

Country Status (16)

Country	Link
US (1)	US7262216B2 (pl)
EP (1)	EP1592687B1 (pl)
JP (1)	JP4664275B2 (pl)
KR (1)	KR20050098889A (pl)
CN (1)	CN1742006A (pl)
AT (1)	ATE397604T1 (pl)
AU (1)	AU2004212026B2 (pl)
BR (1)	BRPI0407360A (pl)
CA (1)	CA2515541A1 (pl)
DE (2)	DE10305739A1 (pl)
ES (1)	ES2304599T3 (pl)
MX (1)	MXPA05008437A (pl)
PL (1)	PL377319A1 (pl)
RU (1)	RU2005128187A (pl)
WO (1)	WO2004072067A1 (pl)
ZA (1)	ZA200507239B (pl)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
JP2008169191A (ja) *	2006-02-20	2008-07-24	Eisai R & D Management Co Ltd	運動ニューロン疾患治療剤
US7678808B2 (en)	2006-05-09	2010-03-16	Braincells, Inc.	5 HT receptor mediated neurogenesis
RU2329044C1 (ru) *	2006-11-16	2008-07-20	Андрей Александрович Иващенко	Лиганды 5-ht6 рецепторов, фармацевтическая композиция, способ ее получения и лекарственное средство
CN106243088B (zh)	2015-06-03	2019-01-04	广东东阳光药业有限公司	取代的哌嗪化合物及其使用方法和用途

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US625198A (en) *		1899-05-16		Of same place
DE4333254A1 (de) *	1993-09-30	1995-04-06	Merck Patent Gmbh	Piperidine und Piperazine
DE19514567A1 (de)	1995-04-20	1996-10-24	Merck Patent Gmbh	Benzofurane
DE19725664A1 (de) *	1997-06-18	1998-12-24	Merck Patent Gmbh	3-Benzylpiperidine
DE19730989A1 (de) *	1997-07-18	1999-01-21	Merck Patent Gmbh	Piperazin-Derivate
EP1070050A1 (en) *	1998-04-08	2001-01-24	American Home Products Corporation	N-aryloxyethyl-indoly-alkylamines for the treatment of depression (5-ht1a receptor active agents)
CN1160332C (zh) *	1998-04-08	2004-08-04	惠氏公司	用于治疗抑郁症的n-芳氧基乙基胺衍生物
TW518218B (en) *	1999-05-27	2003-01-21	Merck Patent Gmbh	Pharmaceutical compositions comprising 1-[4-(5-cyanoindol-3-yl)butyl]-4-(2-carbamoylbenzofuran-5-yl)piperazine or its physiologically acceptable salts for use in the treatment of sub-type anxiety disorders
SK287337B6 (sk) *	2000-11-14	2010-07-07	Merck Patent Gmbh	Použitie zlúčenín, ktoré sú kombinovanými selektívnymi inhibítormi (SSRI) reabsorpcie serotonínu (5-HT) a agonistami receptora 5-HT1A na výrobu liečiva
DE10112151A1 (de) *	2001-03-14	2002-09-19	Merck Patent Gmbh	Substituierte Benzofuran-2-carbonsäureamide

2003
- 2003-02-11 DE DE10305739A patent/DE10305739A1/de not_active Withdrawn
2004
- 2004-01-10 RU RU2005128187/04A patent/RU2005128187A/ru not_active Application Discontinuation
- 2004-01-10 PL PL377319A patent/PL377319A1/pl unknown
- 2004-01-10 CN CNA200480002579XA patent/CN1742006A/zh active Pending
- 2004-01-10 EP EP04701298A patent/EP1592687B1/de not_active Expired - Lifetime
- 2004-01-10 KR KR1020057014402A patent/KR20050098889A/ko not_active Withdrawn
- 2004-01-10 AT AT04701298T patent/ATE397604T1/de not_active IP Right Cessation
- 2004-01-10 WO PCT/EP2004/000125 patent/WO2004072067A1/de not_active Ceased
- 2004-01-10 BR BR0407360-6A patent/BRPI0407360A/pt not_active Application Discontinuation
- 2004-01-10 DE DE502004007318T patent/DE502004007318D1/de not_active Expired - Lifetime
- 2004-01-10 ES ES04701298T patent/ES2304599T3/es not_active Expired - Lifetime
- 2004-01-10 US US10/545,170 patent/US7262216B2/en not_active Expired - Fee Related
- 2004-01-10 CA CA002515541A patent/CA2515541A1/en not_active Abandoned
- 2004-01-10 MX MXPA05008437A patent/MXPA05008437A/es not_active Application Discontinuation
- 2004-01-10 AU AU2004212026A patent/AU2004212026B2/en not_active Ceased
- 2004-01-10 JP JP2006501538A patent/JP4664275B2/ja not_active Expired - Fee Related
2005
- 2005-09-08 ZA ZA200507239A patent/ZA200507239B/en unknown

Also Published As

Publication number	Publication date
DE10305739A1 (de)	2004-08-19
MXPA05008437A (es)	2005-10-19
BRPI0407360A (pt)	2006-01-10
JP2006517209A (ja)	2006-07-20
US7262216B2 (en)	2007-08-28
JP4664275B2 (ja)	2011-04-06
ZA200507239B (en)	2006-06-28
ES2304599T3 (es)	2008-10-16
AU2004212026A1 (en)	2004-08-26
EP1592687A1 (de)	2005-11-09
AU2004212026B2 (en)	2010-07-29
DE502004007318D1 (de)	2008-07-17
CA2515541A1 (en)	2004-08-26
CN1742006A (zh)	2006-03-01
WO2004072067A1 (de)	2004-08-26
EP1592687B1 (de)	2008-06-04
RU2005128187A (ru)	2006-05-10
ATE397604T1 (de)	2008-06-15
KR20050098889A (ko)	2005-10-12
US20060142372A1 (en)	2006-06-29

Legal Events

Date	Code	Title	Description
2007-10-31	DISC	Decisions on discontinuance of the proceedings (taken after the publication of the particulars of the applications)

Publication	Publication Date	Title
ATE355838T1 (de)	2007-03-15	(-)-1-(3,4-dichlorphenyl)-3-azabicyclo (3.1.0)hexan, zusammensetzungen davon und verwendung als dopamin-wiederaufnahme-hemmer
PL367696A1 (pl)	2005-03-07	Pochodne 2-pirolidonu jako agoniści prostanoidu
ATE315022T1 (de)	2006-02-15	Prostaglandinanaloga als ep4-rezeptoragonisten
BG107171A (bg)	2003-07-31	Производни на пурин
WO2003048116A3 (en)	2004-06-10	Esters and amides as ppar-alpha agonists ____________
MXPA03005822A (es)	2004-05-04	Compuestos heterociclicos que tienen actividad antibacteriana, proceso para su preparacion y composiciones farmaceuticas que los contienen.
EA200300519A1 (ru)	2003-12-25	Соединения производных бензотиофена, способ их получения и применения
CA2379021A1 (en)	2001-03-01	New phenylpiperazines
PL377618A1 (pl)	2006-02-06	Benzofuranoksyetyloaminy jako czynniki antydepresyjne i anksjolityczne
MY135916A (en)	2008-07-31	Use of certain affinity nmda antagonists as antidepressants
HRP20040090A2 (en)	2004-12-31	Arylsulfonyl derivatives with 5-ht<sub>6</sub> receptor affinity
WO2004000849A3 (en)	2004-03-25	Tetracyclic arylsulfonyl indoles having serotonin receptor affinity
ATE397604T1 (de)	2008-06-15	Benzofuranderivate und ihre verwendung als antidepressiva und anxiolytika
MXPA04005313A (es)	2004-09-13	Derivados de aminotetralin como antagonistas del receptor muscarinico.
DK1537113T3 (da)	2010-02-15	Arylalkylindoler med serotoninreceptoraffinitet anvendelige som terapeutiske midler, fremgangsmåde til fremstilling heraf og farmaceutiske sammensætninger indeholdende disse
MY137836A (en)	2009-03-31	Isoxazolines derivatives and their use as anti-depressants
PL375259A1 (pl)	2005-11-28	Pochodne pirydynoalkilo-aminoalkilo-1H-indolu hamujące wychwyt zwrotny 5-HT i serotoniny jako antydepresanty i anksjolityki
MXPA05011841A (es)	2006-01-26	Metil-indoles y metil-pirrolopiridinas como agonistas adrenergicos de alfa-1.
SI1517909T1 (sl)	2007-06-30	Novi tetraciklični arilkarbonil indoli, ki imajo afiniteto za serotoninski receptor, uporabni kot terapevtska sredstva, postopek za njihovo pripravo in farmacevtski sestavki, ki jih vsebujejo
MXPA04006115A (es)	2005-06-08	Derivados de imidazoquinolina.
PT1828125E (pt)	2008-08-22	Derivados de arilpiperazina e sua utilização como ligantes selectivos do receptor d3 da dopamina
MX2023010843A (es)	2023-09-21	Análogos, sales, composiciones y métodos de uso de la psilocibina.
AP2001002179A0 (en)	2002-11-30	2-Aminocarbonyl-9h-purine derivatives.
MXPA03002532A (es)	2004-09-06	Nuevos compuestos de indolina, un proceso para su preparacion y composiciones farmaceuticas que los contienen.
TNSN05325A1 (en)	2007-07-10	N-[3-(3-SUBSTITUTED-PYRAZOLO[1,5-a]PYRIMIDIN-7-YL)PHENYL]-SULFONAMIDES, AND COMPOSITIONS, AND METHODS RELATED THERETO